(Q34481198)

2 August 2017

1 reference

title

Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern? (English)

1 reference

2 August 2017

1 reference

C G Dahlöf

1 reference

2 August 2017

N Mathew

series ordinal

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

539-545

1 reference

Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Clinical experiences from Sweden on the use of subcutaneously administered sumatriptan in migraine and cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

The clinical profile of sumatriptan: safety and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Effects of S20749, a close analogue of sumatriptan, on porcine carotid haemodynamics and human isolated coronary artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Effects of avitriptan, a new 5-HT 1B/1D receptor agonist, in experimental models predictive of antimigraine activity and coronary side-effect potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Sumatriptan-induced chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Coronary vasospasm and sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Cardiac arrest following use of sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Vasospasm-induced myocardial infarction with sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Oral sumatriptan-associated transmural myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Transmural myocardial infarction with sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Characteristics and determinants of sumatriptan-associated chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Unstable angina pectoris associated with Imitrex therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Coronary vasospasm induced by subcutaneous sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Zolmitriptan, a 5-HT1B/1D receptor agonist for the acute oral treatment of migraine: a multicentre, dose-range finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Early clinical experience with subcutaneous naratriptan in the acute treatment of migraine: a dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Sumatriptan-induced chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Is chest pain after sumatriptan oesophageal in origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Sumatriptan injection and tablets in clinical practice: results of a survey of 707 migraineurs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Sumatriptan in clinical practice: a 2-year review of 453 migraine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Safety trial with the 5HT1B/1D agonist avitriptan (BMS-180048) in patients with migraine who have experienced pressure, tightness, and/or pain in the chest, neck, and/or throat following sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Chronic hyperalgesia and skin warming caused by sensitized C nociceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

The puzzle of normal coronary arteries in the patient with chest pain: what to do?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Psychological comparison of patients with nutcracker esophagus and irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

Migraine and depression: Association and familial transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1808539.X

10.1046/J.1468-2982.1998.1808539.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference